Önerilen Konular
Önerilen Konular
- COVID-19 8
- COVID-19 (Disease) 8
- Clinical trials 8
- Pneumonia, Viral 8
- SARS-CoV-2 8
- drug therapy 8
- Antiviral agents 6
- Chemotherapy 6
- Coronavirus Infections 6
- Coronavirus infections 6
- Treatment 6
- administration & dosage 6
- Antiviral Agents 4
- Clinical Trials as Topic 4
- Development 4
- Interferon 4
- Therapeutic use 4
- therapeutic use 4
- Clinical Trials, Phase I as Topic 2
- Clinical Trials, Phase II as Topic 2
- Combined Modality Therapy 2
- Communicable Diseases, Emerging 2
- Induced Pluripotent Stem Cells 2
- Interferon-alpha-2 2
- Interferon-beta 2
- Interferons 2
- Killer Cells, Natural 2
- Killer cells 2
- Natural immunity 2
- Nebulizers and Vaporizers 2
-
1
Remdesivir COVID-19 clinical trial
Baskı/Yayın Bilgisi 2020Konular: Tam Metin Erişim
Series
Elektronik İşitsel -
2
Remdesivir COVID-19 clinical trial
Baskı/Yayın Bilgisi 2020Konular: Tam Metin Erişim
Series
Elektronik İşitsel -
3
Interferon-α2b as a therapy for COVID-19
Baskı/Yayın Bilgisi 2020Konular: Tam Metin Erişim
Series
Elektronik İşitsel -
4
Interferon-α2b as a therapy for COVID-19
Baskı/Yayın Bilgisi 2020Konular: Tam Metin Erişim
Series
Elektronik İşitsel -
5
Natural Killer cells as COVID-19 therapy
Baskı/Yayın Bilgisi 2020Konular: Series
Elektronik İşitsel -
6
Natural Killer cells as COVID-19 therapy
Baskı/Yayın Bilgisi 2020Konular: Series
Elektronik İşitsel -
7
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Baskı/Yayın Bilgisi 2020Konular: Tam Metin Erişim
Series
Elektronik İşitsel -
8
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Baskı/Yayın Bilgisi 2020Konular: Tam Metin Erişim
Series
Elektronik İşitsel
